Search results
Trial suggests chemo before, after surgery could help those battling esophageal cancer
Medical Xpress· 12 hours ago"There is considerable disagreement as to whether giving all adjuvant [chemo] therapy upfront versus...
Summer holidays aren't all fun and games for children's fitness
Medical Xpress· 6 hours agoUniversity of South Australia researchers have conducted the first ever review of studies of 14 million school children and what happens to their academic performance, and ...
Beauty in Chaos Releases 'Diving For Pearls' Feat. Wayne Hussey & Cinthya Hussey
Broadway World· 8 hours agoLA-based collective Beauty In Chaos presents 'Diving For Pearls', featuring The Mission trailblazer...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 6 hours agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 1 day agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 5 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel...
Nature· 7 days agoCerebral small vessel disease (cSVD) is a leading cause of stroke and dementia. Genetic risk loci for white matter hyperintensities (WMH), the most common MRI-marker of cSVD in older age, were ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoWerewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered ...
Post hangover: What is the right price for Bordeaux en primeur 2023? | By Philippe Masset
Hospitality Net· 17 hours agoNo two years are alike in the fine wine market, especially in Bordeaux. The 2022 vintage was of...
Citi sets Sensei Biotherapeutics stock to buy with $4 target By Investing.com
Investing.com· 1 day agoOn Monday, Citi resumed coverage of Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating, and a...